Linked Life Data

7571919

Source:http://linkedlifedata.com/resource/pubmed/id/7571919

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-11-22
pubmed:abstractText
Serum levels of glyofibrillar acid protein (GFAP), alpha-2 glycoprotein (A2GP), alpha-1 brain globulin (A1BG), alpha-2 brain globulin (A2BG) were measured in 41 epileptic patients (2 groups--with convulsive and non-convulsive forms of the disease) with the help of "sandwich" variant of enzyme immunoassay and double-centered enzyme immunoassay on the basis of column immunosorption chromatography. Investigations were performed in the interval from the first to the 30th day after the fit. The level of at least one of neurospecific proteins was elevated in 65.2% of patients. The same changes were revealed in one third of patients during the period of 30 days. Frequency discovering of A1BG as compared to A2GP was significantly lower only in patients with convulsive epilepsy. It allowed the authors to suggest, that serum antigenic levels in patients with various forms of epilepsy were different.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1997-7298
pubmed:author
pubmed:issnType
Print
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-1
pubmed:dateRevised
2008-3-31
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[An immunoenzyme analysis of the neurospecific proteins in the blood serum of epilepsy patients].
pubmed:publicationType
Journal Article, English Abstract